About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Texas | 42,055 Studies Near You

Clinical TrialsTexas

Clinical Trials in Texas

Discover 42,055 clinical trials near Texas. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 5341-5360 of 42,055 trials

TerminatedStudy of AEB071 (a Protein Kinase C Inhibitor) in Patients With CD79-mutant Diffuse Large B-Cell LymphomaThis study has two phases, a dose escalation phase and a dose expansion phase.NCT01402440·Duarte, California and 23 others CompletedStudy of Safety, Tolerability, and Efficacy of a Combination Treatment of LJN452 and CVC in Adult Patients With NASH and Liver FibrosisThe purpose of this study was to assess the safety, tolerability, and efficacy of a combination treatment of tropifexor (LJN452) and cenicriviroc (CVC) in adult patients with…NCT03517540·Chandler, Arizona and 64 others

Find Trials by Condition in Texas

Breast Cancerin Texas Lung Cancerin Texas Prostate Cancerin Texas Colorectal Cancerin Texas Melanomain Texas Leukemiain Texas Lymphomain Texas Pancreatic Cancerin Texas Ovarian Cancerin Texas Brain Cancerin Texas Diabetesin Texas

Data from ClinicalTrials.govTerms

CompletedA Study to Evaluate the Pharmacokinetics of JNJ-38518168 in Patients With Mild and Moderate Hepatic Impairment Compared With Patients With Normal Hepatic FunctionThe purpose of this study is to characterize the pharmacokinetics (what the body does to the study medication) of JNJ-38518168 at approximately steady-state (stable medication…NCT01863784·Orlando, Florida and 2 others

CompletedDose Adjusted EPOCH Regimen in Combination With Ofatumumab or Rituximab in Treating Patients With Newly Diagnosed or Relapsed or Refractory Burkitt Lymphoma or Relapsed or Refractory Acute Lymphoblastic LeukemiaThis phase II trial studies how well a dose adjusted regimen consisting of etoposide, prednisone, vincristine sulfate, cyclophosphamide, and doxorubicin hydrochloride (EPOCH)…NCT02199184·Houston, Texas

CompletedA Phase 1, First-In-Human Study of Escalating Doses of Oral TVB-2640 in Patients With Solid TumorsThis first in human phase 1 study of TVB-2640 is being conducted in patients with advanced stage solid malignant tumors.NCT02223247·Scottsdale, Arizona and 10 others

CompletedBrentuximab Vedotin in Patients With CD30-positive Nonlymphomatous MalignanciesThis is an open-label, multicenter, phase 2 clinical trial to evaluate the antitumor activity of brentuximab vedotin as a single agent in patients with CD30-positive…NCT01461538·Birmingham, Alabama and 28 others

CompletedA Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)This proof-of-concept study is designed as a Phase 2, multicenter, randomized, double-blind, placebo controlled study comparing ubenimex with placebo in patients with pulmonary…NCT02664558·Birmingham, Alabama and 30 others

CompletedTrial of Maraviroc (UK-427,857) in Combination With Optimized Background Therapy Versus Optimized Background Therapy Alone for the Treatment of Antiretroviral-Experienced NonCCR5-Tropic HIV-1 Infected SubjectsMaraviroc (UK-427,857), a selective and reversible CCR5 co-receptor antagonist, has been shown to be active in vitro against a wide range of clinical isolates (including those…NCT00098748·Birmingham, Alabama and 76 others

CompletedEdoxaban Compared to Standard Care After Heart Valve Replacement Using a Catheter in Patients With Atrial Fibrillation (ENVISAGE-TAVI AF)When the upper chambers of a person's heart receive or generate irregular electrical signals, it causes abnormal rhythm in the heartbeat. This is called atrial fibrillation.NCT02943785·Birmingham, Alabama and 229 others

CompletedFirst-in-Human Dose Escalation Trial in Subjects With Advanced MalignanciesThis is a Phase 1, first-in-human, open-label, non-randomized, dose escalation, trial to explore the safety, tolerability, pharmacokinetic (PK), pharmacodynamic (PD) and clinical…NCT01971515·Birmingham, Alabama and 14 others

CompletedAn add-on Study to the FIGARO-DKD Study Called FIGARO-BM to Learn About the Link Between Biomarkers (Substances in the Blood Used as Indicators of Biological Processes, Disease Processes or Responses to Medication) and Finerenone in FIGARO-DKD ParticipantsResearchers are looking for a better way to treat people who have chronic kidney disease (CKD), a long-term, progressive decrease in the kidneys' ability to work properly.NCT05013008·Northridge, California and 114 others

CompletedFDG-PET-CT and Biomarkers in Esophageal CancerThe goal of this clinical research study is to learn if the results of a positron emission tomography/computed tomography (PET/CT) scan done 10-14 days after beginning…NCT00833625·Houston, Texas

CompletedStudy Evaluating Single Doses Of SBI-087 in Subjects With Rheumatoid ArthritisThe purpose of this study is to determine the safety and tolerability of single doses of SBI-087 in subjects with rheumatoid arthritis.NCT00641225·Miami, Florida and 5 others

CompletedKYleena Satisfaction Study / Observational Study on User Satisfaction With the Levonorgestrel Intrauterine Delivery System Kyleena (LNG-IUS 12) in New Contraceptive Users and After Switching From Another Contraceptive MethodThe main goal of this non-interventional study (NIS) is to evaluate user satisfaction with Kyleena in a real-life setting and to identify factors which influence user…NCT03182140·Lakewood, Colorado and 18 others

CompletedEvaluation of Glucose Lowering Effect, Safety and Tolerability of CS-917This study will compare glucose lowering with CS-917 compared to placebo after 3 months of treatmentNCT00290940·Birmingham, Alabama and 65 others

CompletedPhase 1 Study of Oral TP-1454This study will evaluate the safety and tolerability of oral TP-1454 in patients with advanced metastatic or progressive solid tumors and anal cancer.NCT04328740·Phoenix, Arizona and 10 others

CompletedA Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)This randomized, multicenter, double-blind, placebo-controlled, parallel-group study will assess the efficacy and safety of lebrikizumab in patients with asthma whose disease…NCT01545440·Pell City, Alabama and 70 others

Terminated"Natural History" Study of ChoroideremiaThe purpose of this study is to understand the rate of progression of all stages of choroideremia using a variety of assessments performed in the clinic including visual field…NCT02994368·Dallas, Texas and 3 others

CompletedPilot Study of Losartan and N-acetylcysteine as Inhibitors of Muscle Oxidative Stress in ElderlyThe general hypothesis is that elderly have diminished nutritive flow to skeletal muscle and impaired capacity for building muscle.NCT01384591·Galveston, Texas

CompletedA Study to Test How Effective and Safe Different Doses of BI 655130 Are in Patients With a Moderate to Severe Form of the Skin Disease Palmoplantar PustulosisThe primary objective is to provide dose-ranging data for 4 dose regimens of BI 655130 compared to placebo on the primary endpoint of percentage change from baseline in PPP ASI at…NCT04015518·Birmingham, Alabama and 87 others

PreviousPage 268 of 2103Next

Heart Diseasein Texas